LBG
ELV icon

Lloyds Banking Group’s Elevance Health ELV Stock Holding History

Lloyds Banking Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-11,750
Closed -$1.41M – 165
2014
Q3 		$1.41M Sell
11,750
-280
-2% -$32.1K 0.38% 78
2014
Q2 		$1.29M Sell
12,030
-139,450
-92% -$14.4M 0.31% 94
2014
Q1 		$15.1M Sell
151,480
-60,050
-28% -$5.43M 0.13% 187
2013
Q4 		$19.5M Buy
211,530
+26,350
+14% +$2.34M 0.18% 147
2013
Q3 		$15.5M Buy
185,180
+79,959
+76% +$6.85M 0.16% 159
2013
Q2 		$8.61M Buy
+105,221
New +$7.87M 0.09% 196

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Lloyds Banking Group's ELV Position: Q4 2014 in Review

Lloyds Banking Group sold out of Elevance Health (ELV) in Q4 2014, closing a stake of 11,750 shares — an estimated $1.41M sold.

Lloyds Banking Group first reported a position in ELV in Q2 2013 and held it in 6 quarters. The position peaked at $19.5M in Q4 2013. 721 funds tracked by Wall St. Rank hold ELV as of Q4 2014.

  • Lloyds Banking Group reported no remaining Elevance Health position as of Q4 2014 after selling out during the quarter.
  • Lloyds Banking Group sold 11,750 Elevance Health shares in Q4 2014, an estimated $1.41M.
  • Lloyds Banking Group first reported a position in Elevance Health in Q2 2013 and held it in 6 quarters.
  • Lloyds Banking Group's Elevance Health position peaked at $19.5M in Q4 2013.
  • 721 funds tracked by Wall St. Rank held Elevance Health as of Q4 2014.

Based on Lloyds Banking Group's 13F filing for Q4 2014, filed 12 Feb 2015.